Midterm outcomes of prospective, randomized, single-center study of the Janus tacrolimus-eluting stent for treatment of native coronary artery lesions

Chinese Medical Journal

Volumn 120, Issue 7, 2007, Pages 552-556

  Han, Ya Ling ^a   Wang, Shou Li ^a   Jing, Quan Min ^a   Yu, Hai Bo ^a   Wang, Bin ^a   Ma, Ying Yan ^a   Luan, Bo ^a   Wang, Geng ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Acute myocardial infarction; Angioplasty; Drug eluting stent; Percutaneous coronary; Transluminal

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; TACROLIMUS;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART DEATH; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE THROMBOSIS; RANDOMIZED CONTROLLED TRIAL;

EID: 34247359496     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200704010-00005     Document Type: Article

References (13)

1. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
2. Han YL, Wang G, Jing QM, Wang SL, Wang ZL, Wang DM, et al. Percutaneous coronary intervention in acute coronary syndrome: single center experience from 4670 patients. Natl Med J China (Chin) 2005; 85: 1040-1044.
3. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents. J Am Coll Cardiol 2006; 48: 2584-2591.
4. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
5. Sousa JE, Costa MA, Abizaid AC, Rensing BJ, Abizaid AS, Tanajura LF, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 2001; 104: 2007-2011.
6. Danzi GB, Capuano C, Sesana M, Baglini R, Bartorelli AL, Trabattoni D, et al. Six-month clinical and angiographic outcomes of the tecnic carbostent™ coronary system: the phantom IV study. J In vasasive Cardiol 2004; 11: 641-644.
7. Kollum M, Farb A, Schreiber R, Terfera K, Arab A, Geist A, et al. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis. Catheter Cardiovasc Interv 2005; 64: 85-90.
8. Scheller B, Grandt A, Wnendt S, Lorenz G, Bohm M, Nickenig G. Comparative study of tacrolimus and paclitaxel stent coating in the porcine coronary model. Z Kardiol 2005; 94: 445-452.
9. Bartorelli A, Trabattoni D, Fabbiocchi F, Montorsi P, Martini SD, Calligaris G, et al. Synergy of passive coating and targeted drug delivery: the tacrolimus-eluting Janus Carbostent. J Interven Cardiol 2003; 16: 499-505.
10. Pache J, Dibra A, Mehili J, Dirschinger J, Schomig A, Kastrati A. Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial. Eur Heart J 2005; 26: 1262-1268.
11. Spaulding C, Henry P, Teiger E, Beatt K, Bramucci E, Carre D, et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006; 355: 1093-1104.
12. Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiquchi H, et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 2006; 47: 2108-2111.
13. Takahashi S, Kaneda H, Tanaka S, Miyashita Y, Shiono T, Taketani Y, et al. Late angiographic stent thrombosis after sirolimus-eluting stent implantation. Circ J 2007; 71: 226-228.